US 11814431
B7-H4 antibodies and methods of use thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11814431 (B7-H4 antibodies and methods of use thereof) held by Five Prime Therapeutics, Inc. expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 48
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61P, A61P35/00